Zack Terranova
About Zack Terranova
Zack Terranova serves as the Director of Intellectual Property at Singular Genomics, where he focuses on due diligence operations and licensing relationships. He holds a PhD in chemistry and has expertise in protein engineering, genetics, optics, imaging, and next-generation sequencing.
Work at Singular Genomics
Zack Terranova serves as the Director of Intellectual Property at Singular Genomics, a position he has held since 2019. In this role, he contributes to due diligence operations and manages licensing relationships, with a focus on the intellectual property aspects of the company's innovations. His responsibilities include overseeing the development and protection of the company's intellectual property portfolio, ensuring that life science inventions are effectively translated into strategic protections such as trade secrets and patents.
Education and Expertise
Zack Terranova holds a Doctor of Philosophy (PhD) in chemistry from the University of Notre Dame. His academic background provides a strong foundation for his expertise in various technical areas, including protein engineering, genetics, optics and imaging, and next-generation sequencing. This expertise supports his work in intellectual property, enabling him to navigate complex scientific concepts and their implications for patent protection and licensing.
Background
Zack Terranova has a background that includes significant involvement in litigation proceedings, where he engages in art analyses and technology landscaping. His experience in these areas allows him to assess and manage risks associated with intellectual property, ensuring that Singular Genomics remains compliant and competitive in the life sciences sector. His technical knowledge complements his legal expertise, making him a valuable asset in intellectual property management.
Achievements
In his role as Director of Intellectual Property, Zack Terranova has developed skills in translating life science inventions into effective intellectual property portfolio strategies. His work includes the implementation of trade secret and patent protection measures, which are critical for safeguarding the company's innovations. His contributions to due diligence operations and licensing relationships have strengthened Singular Genomics' position in the market.